Fidelity Investments’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
Fidelity Investments's UPB Position: Q3 2026 in Review
Fidelity Investments increased its Upstream Bio (UPB) stake by 0.23% in Q3 2026, buying an estimated $122K and bringing the position to 8,181,586 shares worth $43.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1563.
Fidelity Investments first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $204M in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- Fidelity Investments held 8,181,586 shares of Upstream Bio worth $43.1M as of Q3 2026.
- Fidelity Investments bought 18,689 Upstream Bio shares in Q3 2026, an estimated $122K.
- Upstream Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1563 holding.
- Fidelity Investments first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
- Fidelity Investments's Upstream Bio position peaked at $204M in Q4 2025.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.